Rockefeller Capital Management
ZBH icon

Rockefeller Capital Management’s Zimmer Biomet ZBH Stock Holding History

Rockefeller Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
12,354
+79
+0.6% +$6.93K ﹤0.01% 1667
2026
Q1 		$1.11M Buy
12,275
+2,805
+30% +$257K ﹤0.01% 1560
2025
Q4 		$852K Sell
9,470
-407
-4% -$38.6K ﹤0.01% 1620
2025
Q3 		$973K Buy
+9,877
New +$979K ﹤0.01% 1434
2025
Q2 		– Sell
-10,963
Closed -$1.24M – 1793
2025
Q1 		$1.24M Sell
10,963
-71
-0.6% -$7.6K ﹤0.01% 1199
2024
Q4 		$1.17M Buy
+11,034
New +$1.18M ﹤0.01% 1197
2023
Q3 		– Sell
-11,115
Closed -$1.62M – 1843
2023
Q2 		$1.62M Buy
11,115
+2,816
+34% +$383K 0.01% 918
2023
Q1 		$1.07M Sell
8,299
-702
-8% -$88.1K ﹤0.01% 1044
2022
Q4 		$1.15M Sell
9,001
-4,164
-32% -$483K 0.01% 956
2022
Q3 		$1.38M Buy
13,165
+1,278
+11% +$140K 0.01% 900
2022
Q2 		$1.25M Sell
11,887
-1
-0% -$119 0.01% 929
2022
Q1 		$1.52M Sell
11,888
-172
-1% -$20.7K 0.01% 904
2021
Q4 		$1.49M Sell
12,060
-2,360
-16% -$309K 0.01% 908
2021
Q3 		$2.05M Buy
14,420
+1,433
+11% +$211K 0.01% 740
2021
Q2 		$2.03M Buy
12,987
+2,473
+24% +$401K 0.01% 714
2021
Q1 		$1.63M Buy
10,514
+2,148
+26% +$333K 0.01% 639
2020
Q4 		$1.25M Buy
8,366
+1,614
+24% +$228K 0.01% 635
2020
Q3 		$892K Buy
6,752
+1,598
+31% +$209K 0.01% 625
2020
Q2 		$597K Buy
5,154
+189
+4% +$21.8K 0.01% 652
2020
Q1 		$487K Sell
4,965
-51
-1% -$6.68K 0.01% 611
2019
Q4 		$729K Sell
5,016
-687
-12% -$94.8K 0.01% 504
2019
Q3 		$760K Buy
5,703
+245
+4% +$31.6K 0.01% 433
2019
Q2 		$624K Sell
5,458
-219
-4% -$25.6K 0.01% 410
2019
Q1 		$704K Buy
5,677
+244
+4% +$27.7K 0.01% 424
2018
Q4 		$547K Sell
5,433
-3,992
-42% -$449K 0.01% 310
2018
Q3 		$1.2M Hold
9,425
– – 0.02% 197
2018
Q2 		$1.02M Buy
9,425
+52
+0.6% +$5.66K 0.02% 210
2018
Q1 		$992K Buy
+9,373
New +$1.09M 0.02% 214

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Rockefeller Capital Management's ZBH Position: Q2 2026 in Review

Rockefeller Capital Management increased its Zimmer Biomet (ZBH) stake by 0.64% in Q2 2026, buying an estimated $6.93K and bringing the position to 12,354 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1667.

Rockefeller Capital Management first reported a position in ZBH in Q1 2018 and has held it in 28 quarters since. The position peaked at $2.05M in Q3 2021. 911 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Rockefeller Capital Management held 12,354 shares of Zimmer Biomet worth $1.06M as of Q2 2026.
  • Rockefeller Capital Management bought 79 Zimmer Biomet shares in Q2 2026, an estimated $6.93K.
  • Zimmer Biomet made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #1667 holding.
  • Rockefeller Capital Management first reported a position in Zimmer Biomet in Q1 2018 and has held it in 28 quarters since.
  • Rockefeller Capital Management's Zimmer Biomet position peaked at $2.05M in Q3 2021.
  • 911 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.